XtalPi Introduces AI-Powered XGlue Platform for Molecular Glue Drug Discovery

Feb 2, 2026
XtalPi unveiled its new AI-driven XGlue platform at the 2026 International Symposium on Molecular Glue Drug Discovery in Shanghai, aiming to accelerate systematic discovery of molecular glue therapeutics.

XtalPi unveiled its AI-driven XGlue platform at the 2026 International Symposium on Molecular Glue Drug Discovery in Shanghai, announced in a press release. The event gathered scientists, biopharma innovators, and investors to discuss advances in targeting previously undruggable proteins.

XGlue integrates physics-based AI modeling with an autonomous synthesis workflow to form a closed-loop design–make–test system. This setup allows rapid iteration and expands the range of potential targets for molecular glue therapeutics.

Speakers from institutions including Stanford University, EPFL, and the Chinese Academy of Sciences presented research on computational design and rational discovery of molecular glues for diseases with unmet medical needs. Industry participants from companies such as Sanofi and Betta Pharma joined discussions on improving collaboration between academic research, industrial development, and clinical applications.

The symposium concluded with consensus on the importance of integrating AI, robotics, and cross-sector partnerships to advance protein degradation and accelerate the translation of molecular glue therapies into clinical use.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Guide
Specialist Ambient Medical Scribe Vendors

Specialist Ambient Medical Scribe Vendors

AI scribes that turn medical consultations into draft clinical notes

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.